Nantahala Capital Management »

Reneo Pharmaceuticals shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $846k 548k 1.55

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Eli Lilly & Co. Put Option (LLY)
Eli Lilly & Co. Put Option (LLY)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Spdr Ser Tr S&p Biotech (XBI)
Spdr Ser Tr S&p Biotech (XBI)
Peloton Interactive Cl A Com (PTON)
Peloton Interactive Cl A Com (PTON)
Grand Canyon Education Put Option (LOPE)
Grand Canyon Education Put Option (LOPE)
Imax Corp Cad (IMAX)

View all positions for Nantahala Capital Management

Top funds holding Reneo Pharmaceuticals

NEA Management Company
Tang Capital Management
Highbridge Capital Management
Carlyle
BML Capital Management
RiverVest Venture Management
Octagon Capital Advisors
Aisling Capital Management
Vanguard Group
Nantahala Capital Management
Vestal Point Capital
Aldebaran Capital
Renaissance Technologies
Acuitas Investments
BlackRock

View all funds holding Reneo Pharmaceuticals